Biomarker Study for Cancer
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to uncover new biomarkers (biological indicators) to enhance the diagnosis and treatment of diseases such as diabetes, breast cancer, and endometriosis. Researchers will study proteins and genetic materials in individuals with these conditions and in healthy individuals. The goal is to develop improved diagnostic tools and treatments. This trial suits those diagnosed with specific conditions like diabetes or breast cancer, as well as healthy individuals without chronic diseases. As an unphased trial, participants can contribute to groundbreaking research that may lead to significant advancements in medical diagnostics and treatments.
What prior data suggests that this study's methods are safe?
This study aims to understand how proteins and genes change in both sick and healthy individuals. It does not test any new treatments or drugs, so no new safety information is available. The main goal is to collect and analyze data to learn more about different diseases. Participants will not receive any new medicines, eliminating the risk of experimental treatment. Instead, the study may involve taking samples like blood or tissue for analysis. These standard procedures are generally considered safe. For any concerns, discussing them with the study team or your doctor is advisable.
Why are researchers excited about this trial?
Researchers are excited about this trial because it's focused on identifying biomarkers for conditions like Diabetes, NASH, Breast Cancer, and Endometriosis. Unlike traditional treatments that focus directly on symptoms or disease progression, this study aims to uncover specific biological markers that could lead to earlier and more precise diagnoses. By understanding these biomarkers, future treatments could be tailored more effectively to individual patients, potentially improving outcomes and reducing side effects. This approach represents a shift towards personalized medicine, making it a groundbreaking step in how these conditions might be understood and treated.
What evidence suggests that this trial's methods could be effective for discovering biomarkers in cancer?
This trial examines changes in proteins and genes to discover new diagnostic and treatment methods for diseases. Rather than focusing on a specific treatment, it investigates how various diseases affect the body at a molecular level. The trial includes two groups: subjects with conditions such as diabetes, NASH, breast cancer, endometriosis, or other designated conditions, and healthy subjects with no history of chronic disease. The goal is to identify new biomarkers, which act as disease fingerprints in the body, and observe how they differ between individuals with various conditions and healthy individuals. Through this research, the aim is to develop better tests and treatments in the future. This trial does not provide direct evidence of a treatment's effectiveness, as it primarily gathers information to aid in developing future therapies.
Are You a Good Fit for This Trial?
This study is for individuals aged 20-39 or 70-79 who identify as Caucasian/Non-Hispanic and are citizens of the US or Canada. Participants should generally be in good health, without any specific medical conditions mentioned.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Specimen Collection
Collection of high-quality tissue, whole teeth, and biofluid specimens from consented subjects
Analysis
Testing specimens and associated clinical data to confirm pathology diagnosis and assess RNA and DNA integrity
Follow-up
Participants are monitored for safety and effectiveness after specimen collection and analysis
What Are the Treatments Tested in This Trial?
Find a Clinic Near You
Who Is Running the Clinical Trial?
Audubon Bioscience
Lead Sponsor